Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
Lamellar ichthyosis is a congenital disease of the skin with a generalized scaling. The
primary activity of liarozole is considered to be the inhibition of the degradation of a
substance called retinoic acid, which is the principal endogenous regulator of growth and
differentiation of epithelial tissues in mammals. The current study intends to evaluate the
efficacy and safety in patients with lamellar ichthyosis.